Struggling with a thin endometrium during IVF? Curious about strategies that can improve implantation and success rates?
In this expert webinar, Dr Harry Karpouzis, Founder & Scientific Director of IVF Pelargos Fertility Group, explains what thin endometrium really means, how it affects implantation, and what strategies can be used to improve outcomes. Drawing on real clinical cases and experience, this session explores both standard and advanced approaches to managing thin uterine lining in IVF
Hosted by Liadh Fitzgerald, CEO & Founder of the Women’s Health Network (WHN), Functional Medicine Practitioner and Fertility Educator, known for her 360° approach to women’s health and emotional wellbeing.
A thin uterine lining can lower the chances of implantation, but as Dr Harry Karpouzis, outlined in a webinar, it is often a problem that can be investigated, treated, and sometimes worked around successfully.
The endometrium is the inner lining of the womb where an embryo implants after embryo transfer. In IVF, doctors look at both its thickness and its appearance on ultrasound. A lining that looks healthy and trilaminar endometrium on scan is generally more reassuring than one that appears echogenic too early.
For embryo transfer, a good endometrial thickness is usually 7 to 12 millimetres. Ideally, it is more than 8 millimeters, and sometimes more than 9 millimeters may be even better. A thin endometrium is typically defined as less than 7 millimetres at the time of transfer, whether the cycle is fresh or frozen.
That threshold matters because implantation rates appear to fall when the lining is less than 7 millimetres. There is also some evidence that miscarriage risk may be higher when the lining is thin. Still, thin lining is not the same thing as no chance. Pregnancy can happen even when the endometrium does not reach the textbook target, which is why the next step is usually not to give up, but to find out why the lining is thin in the first place.
A persistently thin endometrium is not one single diagnosis. It is a sign that something may be interfering with the lining’s ability to grow properly in response to hormones.
One of the most important causes is scar tissue inside the uterus. This can happen after procedures such as D&C following miscarriage or termination, polypectomy, fibroid removal, or cesarean section. Surgery can trigger inflammation and adhesions, and those changes may leave the lining thinner than expected. In more severe cases, this falls under Asherman’s syndrome, where scar tissue can cause major problems with endometrial function even after it has been removed.
Blood flow is another recurring issue. Reduced blood supply to the uterus can make it harder for the lining to develop. This may be seen after surgery, with surgical complications, or in conditions such as adenomyosis, which can also disturb the boundary between the lining and the muscle of the womb, increase inflammation, and create hormonal resistance.
Hormonal response matters too. Sometimes the body simply does not respond to estrogen as expected, even when the dose seems adequate. Problems with endometrial thickness are also seen in PCOS, especially lean PCOS and in women with insulin resistance. Missed ovulation can contribute as well, because progesterone may be secreted at the wrong time and thin the lining.
Infection and inflammation are another major part of the picture. Acute or chronic infection can affect the endometrium, and chronic infection is usually referred to as endometritis. Local immune activity may also play a role, since inflammation can alter the immunology of the lining itself.
And sometimes, even after a full work-up, no clear cause is found. That uncertainty is frustrating, but it does not mean there are no options.
Before moving on to more complex explanations, the basics need to be checked. The first question is whether estrogen levels are actually high enough. Blood tests can help confirm that, especially in frozen embryo transfer cycles where a minimum estrogen level should be reached.
If someone is taking 6 milligrams of oral estrogen and the lining is still lagging, the dose may be increased, or the route changed. Some units use doses up to 12 milligrams by mouth. At the same time, there is no clear evidence that more than 8 milligrams truly improves endometrial thickness. That makes the route of administration important. Vaginal estrogen, patches, or a combined approach can sometimes work better than simply pushing the oral dose higher.
This is one reason IVF plans often need to be individualised. A lining that does not respond in one protocol may respond in another, and a patient who fails to thicken on a medicated cycle may do better in a natural or semi-natural one.
If the lining remains thin, hysteroscopy becomes one of the most important investigations. It allows the uterine cavity to be examined directly and can reveal scar tissue, adhesions, subtle signs of chronic endometritis, or other pathology that may not be obvious on routine imaging.
That matters because the treatment depends on what is found. If adhesions are present, the main treatment is hysteroscopic removal. Because adhesions can come back, a coil may be placed afterwards, and estrogen pretreatment may be used before transfer. Even then, the endometrium may not fully recover its function, especially in more severe scarring.
Hysteroscopy is also valuable when infection is suspected. Recognising the visual signs of chronic endometritis allows targeted biopsies to be taken. Those biopsies can then be used for testing for chronic infections and, in selected cases, for immunology assessment.
A very thick lining can also justify hysteroscopy. An endometrium above 12 millimetres is not necessarily a major problem, but if it stays persistently thick, it can sometimes hide polyps, micropolyps, or a chronic infection environment.
Once the likely cause is identified, treatment becomes more targeted.
For scar tissue and adhesions, hysteroscopic treatment is the mainstay. For blood-flow problems, medications such as aspirin and Viagra are sometimes used. These may be considered when blood flow has been affected by surgery, adenomyosis, or related problems, although the evidence supporting Viagra is becoming less and less.
For chronic infection, treatment may include targeted antibiotics and support for the endometrial environment. In one case presented, testing showed mycoplasma and reduced lactobacilli, suggesting a deranged endometrial flora. After 10 days of targeted antibiotics and probiotics, the lining improved enough for transfer.
In selected unexplained or inflammatory cases, newer therapies may be added. PRP is used as a regenerative treatment made from the patient’s own blood, processed to concentrate growth factors and cytokines. G-CSF may help by altering local endometrial immunology and, in some unexplained cases, has added a few millimeters to the lining. Neither approach has conclusive evidence yet, but both have some supportive data.
For persistent Asherman’s syndrome that does not respond to PRP, stem cell treatment has been used experimentally. In the approach described in the webinar, stem cells are taken from abdominal fat tissue and injected hysteroscopically beneath the endometrium.
Steroids may also have a role in selected immunological cases. And when the problem appears to be the transfer protocol itself, changing the protocol may be more effective than adding more medication. Some unexplained thin-lining cases improve when drugs such as Gonapeptyl or Arvekap are omitted and transfer is done in a natural cycle or semi-natural cycle instead.
The clearest message from the cases presented was that the same ultrasound finding can have very different causes.
One patient, 35 years old, had previously had a transfer cancelled when her lining reached only 5.5 millimetres despite high-dose oral estrogen. In another attempt, after 18 days of estrogen replacement plus patches, aspirin, and Viagra, the endometrium reached only 6.5 millimetres, and the transfer failed. A repeat hysteroscopy later identified signs of chronic endometritis, and targeted biopsies were taken. Testing showed mycoplasma and reduced lactobacilli. After 10 days of targeted antibiotics and probiotics, she restarted high-dose estrogen plus patches. This time, after 18 days, the lining reached 7.5 millimetres and looked healthy and trilaminar. A 4AA blastocyst was transferred, followed by a positive test and a live birth.
Another patient, 39 years old, had severe adenomyosis and endometriosis, plus two spontaneous miscarriages that had both been managed with D&C. During IVF, she produced one chromosomally normal embryo after PGT-A, making the transfer especially high stakes because she also had poor ovarian reserve. Her lining never exceeded 5.5 millimetres during stimulation, and Doppler ultrasound showed reduced blood flow. Hysteroscopy found adhesions, likely related to the previous D&Cs, and these were treated. She also underwent testing for chronic infection and immunology. Chronic endometritis testing was negative, but immunology testing suggested an overactive immune system linked to chronic inflammation. She received one dose of a GnRH agonist, then 8 milligrams per day of oral estrogen plus patches, along with aspirin, Viagra, steroids, and a combination of G-CSF and PRP. On day 12, the lining measured 6.2 millimetres. 3 days later, it was 6.8 millimetres. By day 18, it reached 7.4 millimetres and was trilaminar. A euploid 4AB embryo was transferred, and the cycle resulted in a live birth.
A third case involved a slim woman with PCOS and insulin resistance who had already had two failed embryo transfers and three miscarriages. In previous transfers, her lining never reached more than 6.5 millimetres. She underwent IVF with a short antagonist protocol and produced four day-5 blastocysts. PGT-A showed one euploid embryo and one low-mosaic embryo. Hysteroscopy and testing for immunology and chronic infection were normal. On a medicated preparation cycle, the endometrium measured 6.2 millimetres on day 12 and stayed the same on day 15, even after G-CSF, so the transfer was cancelled. A natural-cycle trial then showed something important: the lining remained thin until she ovulated naturally on day 23, when it reached 8 millimetres. That pointed to a protocol-related problem rather than hidden uterine disease. She was started on metformin, and a later semi-natural cycle was used for transfer. As ovulation approached, the lining reached 7.9 millimeters and was trilaminar. A 4AA embryo was transferred, followed by a positive pregnancy test and a live birth.
These cases make the practical lesson hard to miss. Thin lining is not one problem with one fix. It may reflect infection, adhesions, blood-flow issues, inflammation, hormonal resistance, or simply the wrong transfer protocol.
This is often the hardest decision for patients. The preferred target is a trilaminar lining that is more than 8 millimetres. A lining between 7 and 8 millimetres can still be acceptable for transfer if it looks normal on ultrasound and the reasons for the thinner lining have been investigated.
Below 7 millimetres, implantation chances are lower, but transfer is not automatically ruled out. In carefully investigated cases, transfer may still go ahead, and pregnancies can still happen. Dr Harry Karpouzis said he has seen positive results even with transfers at 6 millimetres or 5 millimetres.
That does not mean thin lining should be ignored. It means the decision is individualised. If a patient has already had a thorough work-up, no treatable cause is found, and the embryo is precious, the balance may shift toward proceeding rather than cancelling repeatedly in pursuit of a perfect number.
A persistently thin lining deserves a structured review rather than another identical cycle. Useful questions include:
Some patients also ask about supportive measures. Reports exist for adjuvant treatments such as pentoxifylline, vitamin E, omega-3, and vitamin D, which may help through antioxidant or anti-inflammatory effects. Acupuncture may also be used as an adjuvant treatment, with some evidence and some data suggesting it may help reduce endometrial thickness. These approaches are not substitutes for proper investigation, but they may be considered alongside standard treatment.
A thin endometrium can be one of the most discouraging problems in IVF because it often leads to cancelled transfers and repeated disappointment. But it is not a dead end. A lining that stays below the target may be signalling scar tissue, infection, inflammation, blood-flow problems, hormonal resistance, or simply a protocol that does not suit that patient.
The most hopeful part of the webinar was not that every case can be fixed perfectly. It was that careful investigation that often changes the picture. A lining that once stalled at 5.5 millimetres may reach 7.5 millimetres after treatment. A medicated cycle that repeatedly fails may become a successful semi-natural cycle. And even when the endometrium never becomes ideal, pregnancy can still happen.
For patients facing this problem, the goal is not just to chase a number on a scan. It is to understand why the lining is thin, treat what can be treated, and choose the transfer plan that gives the embryo the best possible chance.
After 6 months of downregulation, the body is effectively in an artificial menopause for a period of time, so it is normal for the endometrium not to become thick and for periods not to return immediately. If some time passes, depending on age and ovarian reserve, estrogen levels in the body may return to normal, and the effect of the medication may lessen, allowing the endometrium to thicken by itself.
If this is in the context of IVF and embryo transfer after 6 months of injections, that prolonged downregulation will not help endometrial thickness. Estrogen replacement treatment with high doses of estrogen can be tried at the time of embryo transfer to see how much the endometrium responds. Many times, the endometrium can still increase properly with estrogen replacement and allow transfer.
There are many possible reasons, and these need to be investigated. First, confirm that the estrogen dose is adequate. The dose can be increased, and the route of administration can be changed because that sometimes improves the response.
Further investigation should include chronic infections, scar tissue, immunology, and blood flow. If a cause is found, it can be treated, and the endometrial thickness may improve. In many cases, no cause is found. In those situations, changing the embryo transfer protocol can help.
If all causes are ruled out, embryo transfer is sometimes still performed with an endometrium less than 7 millimetres, and this can work quite well, especially in very slim women.
An endometrium of 8 millimetres or more that is trilaminar and looks normal on ultrasound is absolutely acceptable for embryo transfer. Ideally, the endometrium is more than 8 millimetres.
Even between 7 and 8 millimetres, transfer can still be considered if the reasons for the thinner lining have been investigated and ruled out. A lining of 7-8 mm can be acceptable for embryo transfer, especially if it is trilaminar and appears normal on ultrasound.
An endometrium of 8 millimeters, or even 7 to 8 millimeters, can be acceptable for embryo transfer, especially if it is trilaminar and looks normal on ultrasound.
If another attempt is needed, the estrogen dose can be increased, the route of estrogen can be changed, and hysteroscopy should be considered to make sure nothing is being missed. Biopsies can also be taken to investigate chronic infections, scar tissue, immunology, and blood flow. If everything is ruled out and the estrogen dose is already high enough, transfer can still proceed with an endometrium between 7 and 8 millimetres.
Some vitamins and supplements have reports behind them, including pentoxifylline, vitamin E, omega-3, and vitamin D. These may help because they have antioxidant and anti-inflammatory effects and may support endometrial preparation before IVF.
However, if the endometrium remains persistently thin even after estrogen replacement, further investigation is needed to identify any hidden cause.
There is some evidence and some data suggesting acupuncture may help with endometrial thickness. When performed by a good acupuncturist, it can be used as an adjuvant treatment alongside other treatments, and there have been cases that responded well. It is reasonable as an adjuvant treatment in a thin endometrium with a good acupuncturist.
There is no specific conclusion here for reflexology, because there is no familiarity with the data for reflexology specifically.
Water intake is not specifically considered to affect endometrial thickness. However, a healthy lifestyle is always recommended before IVF.
Vitamin E and vitamin D have some data and reports behind them as antioxidant treatments that may help in some cases, so they can be used as adjuvant treatments.
An endometrium thicker than 12 millimetres is not necessarily a major problem. However, a persistently thick endometrium can sometimes hide micropolyps or polyps.
In such cases, it is advisable to investigate with hysteroscopy to make sure there is not a proper polyp being missed on a very thick endometrium or a micropolyp environment, which can sometimes be associated with chronic infections. If hysteroscopy is normal, there is usually no major concern.
Donor eggs are eggs from another woman. They are used when there is very poor ovarian reserve or an older age group, because egg quality depends on age.
In women older than 43, 44, or 45, the chances of IVF success with their own eggs are very low, and the chances are much better with donor eggs because donor eggs usually come from women younger than 30 years old. The important step is to have a proper consultation about the chances and decide whether using eggs from another woman, who can be matched to physical characteristics, is acceptable.
